ACTIVE_NOT_RECRUITING

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Talk to us

Conditions

Preeclampsia PostpartumPreeclampsiaPostpartum GLS LevelsPostpartum Activin A LevelsCardiac Postpartum TherapyHypertensionCardiovascular disease

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).

Official Title

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

Quick Facts

Study Start:2022-10-27
Study Completion:2026-11-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05534932

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 45 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Adults between 18 and 45 years of age
  2. 2. African American
  3. 3. \>120/80 BP at the time of their 6-month visit in the PARENT study
  4. 4. Diagnosed with preeclampsia
  5. 5. Initially presented to University of Chicago Medical Center (UCMC) for a Singleton Gestation Delivery
  6. 6. Completed the 6 month visit in the PARENT study
  1. 1. Those who cannot provide consent
  2. 2. patients with preexisting cardiomyopathy, ischemic or valvular heart disease, pulmonary disease, diabetes mellitus, chronic kidney disease, multiple gestations,
  3. 3. Unable to operate the RPM tablet device

Contacts and Locations

Principal Investigator

Sajid H Shahul, MD PHD
PRINCIPAL_INVESTIGATOR
University of Chicago

Study Locations (Sites)

University of Chicago Hospital
Chicago, Illinois, 60637
United States

Collaborators and Investigators

Sponsor: University of Chicago

  • Sajid H Shahul, MD PHD, PRINCIPAL_INVESTIGATOR, University of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-27
Study Completion Date2026-11-01

Study Record Updates

Study Start Date2022-10-27
Study Completion Date2026-11-01

Terms related to this study

Keywords Provided by Researchers

  • Preeclampsia
  • Postpartum GLS Levels
  • Postpartum Activin A Levels
  • Cardiac Postpartum Therapy
  • Hypertension
  • Cardiovascular disease

Additional Relevant MeSH Terms

  • Preeclampsia Postpartum